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Abstract
Background: In April 2009, a novel swine-derived influenza A virus (H1N1pdm) emerged and rapidly spread around the
world, including Japan. It has been suggested that the virus can bind to both 2,3- and 2,6-linked sialic acid receptors in
infected mammals, in contrast to contemporary seasonal H1N1 viruses, which have a predilection for 2,6-linked sialic acid.
Methods/Results: To elucidate the existence and transmissibility of a2,3 sialic acid-specific viruses in H1N1pdm, amino acid
substitutions within viral hemagglutinin molecules were investigated, especially D187E, D222G, and Q223R, which are
related to a shift from human to avian receptor specificity. Samples from individuals infected during the first and second
waves of the outbreak in Japan were examined using a high-throughput sequencing approach. In May 2009, three
specimens from mild cases showed D222G and/or Q223R substitutions in a minor subpopulation of viruses infecting these
individuals. However, the substitutions almost disappeared in the samples from five mild cases in December 2010. The
D187E substitution was not widespread in specimens, even in May 2009.
Conclusions: These results suggest that a2,3 sialic acid-specific viruses, including G222 and R223, existed in humans as a
minor population in the early phase of the pandemic, and that D222 and Q223 became more dominant through human-to-
human transmission during the first and second waves of the epidemic. These results are consistent with the low
substitution rates identified in seasonal H1N1 viruses in 2008.
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Introduction
In April 2009, a novel swine-derived influenza A virus (H1N1pdm)
emerged and spread rapidly around the world [1,2], causing the
World Health Organization to declare a pandemic in June. To date,
most countries have confirmed infections by the new virus.
Since the first appearance of H1N1pdm, one particular amino
acid substitution {aspartic acid to glycine at position 222 (D222G)}
within the hemagglutinin (HA) molecule has appeared sporadically
[1,3,4,5]. The D222G substitution is known to cause a shift from
a2,6-sialic acid receptor specificity to mixed a2,3/a2,6-sialic acid
receptor specificity [6,7]. It is noteworthy that G222 is highly
conserved among avian viruses [8]. Previously, a2,3-specific avian
viruses have been isolated from patients during the initial phases of
thepandemicsof1957and 1968,and avianHAinhumanshasbeen
shown to be selected for increased affinity for the a2,6 receptor [8].
Also, the G222 substitution was present in the Spanish Flu out-
break of 1918 [9]; however, the existence and transmissibility of
H1N1pdm a2,3 sialic acid-specific viruses remain unclear.
To identify whether a2,3 sialic acid-specific viruses, which re-
plicate well in swine, were spread during the early phase of the
H1N1pdm pandemic and whether a2,3 sialic acid-specific viruses
are easily transmitted, the nucleotide sequences of the HA receptor
binding site of H1N1pdm in clinical specimens were determined in
this study.
Several specimens obtained from mild H1N1pdm cases during
the first (May 2009) and second (Dec 2010) waves of the epidemic
in Japan were analyzed. In addition to the D222G substitution, we
focused on two other substitutions {aspartic acid187glutamic acid
(D187E) and glutamine223argine (Q223R)}, known to be critical
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acid receptor specificity [8,10]. Changes in HA amino acid diver-
sity were identified in individual cases using a high-throughput
sequencer.
Results
Sequencing analysis of H1N1pdm HA receptor binding
site (RBS) from nasal specimens in May 2009
Three nasal swabs (#1–#3) from mild H1N1pdm cases were
obtained in May 2009 in Osaka, Japan. Total RNA was extracted
from each sample and the receptor binding site (RBS) within HA
was successfully amplified using One Step RT-PCR. The PCR
products (369 bp) were cloned into pGEM-T easy vector and
analyzed by conventional Sanger technology. More than 100
clones in each specimen were sequenced, and the deduced amino
acid sequences were analyzed (Figures 1, S1, S2, and S3). The
substitution rate of the deduced amino acids was 0.29–0.41%
(average: 0.34%) in the three samples, and mutations commonly
observed in more than two patients are listed in Table 1. Four
substitutions, K119N, N125D, D222G, and Q223R, were
detected in more than 2.0% of the samples (Table 1). Among
these substitutions, D222G and Q223R had already been shown
to be critical for receptor binding and to cause a shift from a2,6 to
a2,3 sialic acid receptor specificity [10]. In addition, the D187E
substitution could be critical for the human-to-avian–type receptor
switch [9]. A homology modeling and docking study also showed
that D222G and Q223R mutants had reduced affinity for the a2,6
sialic acid-linked receptor (Figure S4). Thus, we focused on these
five mutations and tried to measure the mutation ratio of un-
isolated viruses in upper respiratory airways. For a larger scale
analysis, the PCR products were examined via a high-throughput
sequencing approach using a 454/Roche GS-Junior sequencer.
Deep sequencing of more than 3,000 clones (reads) per
specimen showed high rates of amino acid diversity, with the
K119N, N125D, D222G, and Q223R substitutions in specimens
#1–#3 (Table 2). The results obtained by deep sequencing were
consistent with those obtained using Sanger sequencing (Table 1).
The D187E substitution was also identified in two specimens
through deep sequencing analysis; however, the substitution rate
was only slightly increased in one of these (by 0.72% in specimen
#2) (Table 2). These results suggest that a2,3 sialic acid-specific
viruses, including G222 and/or R223, were present as a minor
population in the upper respiratory tract even in mild cases.
Multiple passages of H1N1pdm viruses in embryonated
chicken eggs
To elucidate how the genomic diversity (and population) of the
RBS, including the D222G and/or Q223R substitutions, might
change, we inoculated these specimensinto embryonated chicken eggs
and serially passaged them five or six times in eggs. Hemagglutination
was not detected in any samples of the first passage (P1) but was
detected in the third or fourth passage and showed 2
5 to 2
6
hemagglutination titers on the fifth or sixth passage (P5 or P6) (Figure
S5). PCR products amplifying the same region as in Figure 1 were
prepared from early- and late-passaged viruses (P1 and P5/P6), as well
as MDCK-passaged viruses (except #3). The amplicons, approxi-
mately 200–500 reads, were examined using deep sequencing.
Figure 1. Alignment of the amino acid sequences including D187E, D222G, and Q223R mutants within the receptor binding site of
H1N1pdm hemagglutinin. E187, G222, and R223 variants obtained from three clinical specimens (#1, #2, and #3) from the first wave of the
outbreak. Three clinical nasal swabs were each subjected to RNA extraction, RT-PCR, and TA cloning. More than one hundred clones per specimen
were sequenced using conventional Sanger technology. Positions 187, 222, and 223 are shown in bold and are underlined.
doi:10.1371/journal.pone.0030946.g001
Table 1. Deduced amino acid mutations commonly observed
in more than two patients in May 2009.
HA position Wild type Mutant Mutant Number
a Ratio (%)
119 K N 8 2.6
125 N D 9 2.9
129 N S 4 1.3
145 Y H 2 0.6
147 N D 2 0.6
154 K E 4 1.3
157 S P 3 1.0
160 K E 2 0.6
179 I T 3 1.0
182 P Q 5 1.6
187 D E 5 1.6
191 L P 4 1.3
204 S P 3 1.0
210 F L 2 0.6
214 I V 2 0.6
222 D G 8 2.6
223 Q R 10 3.2
aNumber of each mutant clone out of a total of 313 sequenced clones (#1–#3
specimens).
doi:10.1371/journal.pone.0030946.t001
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higher rates in the early passaged (P1) viruses (Table 3) than in
the parental viruses (Table 1). More than half (98.6%, 95.0%,
and 59.7% in #1, #2, and #3, respectively) possessed either
D222G or Q223R substitutions (Table 3). K119N, N125D and
D187E mutations were also detected at higher ratios in the P5
or P6 passages than in the P1 passage, suggesting that these
mutations were being selected for effective growth in avian cells.
We also detected these substitutions at a lower level in the MDCK-
passaged viruses compared with the egg-passaged viruses (Table 3).
In contrast to the HA gene, no amino acid substitutions were de-
tected in the RNA polymerase B2 (PB2), RNA polymerase B1
(PB1 and PB1-F2), RNA polymerase A (PA), neuraminidase (NA),
matrix proteins (M1 and M2) and non-structural proteins (NS1
and NS2) of the P5/P6 viruses compared with the nucleotide
sequence of the original H1N1pdm derived from the #2 clinical
specimen (data not shown).
P5/P6 in #1, #2, and #3 specimens reduced hemagglutination
titers when RBCs were treated with a2,3 sialidase whereas the
titers did not change in MDCK-passaged viruses (Table 4). These
results suggested that egg-passaged viruses, including G222 and/or
R223, were a2,3 sialic acid receptor tropic and that MDCK-
passaged viruses including D222 and Q223 had a2,6 sialic acid
receptor specificity. From these results, we can extrapolate that the
major populations in the original specimens #1–#3 had a2,6
sialic acid receptor tropism. These results are coincident with the
homology modeling and docking of D222G and Q223R mutants
(Figure S4).
Deep sequencing analysis of H1N1pdm HA D222G or
Q223R mutants from the second wave of the outbreak
To elucidate the transmissibility of the G222 and/or R223 viruses
inhumans, fivenasal swabs (#4–#8)obtained from individuals with
a mildcaseofH1N1pdminDecember2010wereexaminedbydeep
sequencing analysis. The same region of HA RBS (369 bp) as shown
inFigure1wasamplifiedbyOneStepRT-PCR.Theresultsshowed
that, by December 2010, both the G222 and R223 variants had
almost disappeared (0.01–0.07% and 0.47–0.63%, respectively)
(Table 2). The K119N mutation frequency also shifted to an un-
detectable level except for one specimen (#8). By contrast, the
N125D mutation could still be detected (0.66–2.15%; average,
1.42%) (Table 2). Taken together, these results suggest that the
H1N1pdm D222 and Q223 variants are competent for human-to-
human transmission but that the a2,3 sialic acid-specific G222 and
R223 mutations resulted in low transmissibility. We also examined
the substitutionrates inseasonal H1N1virusesusing fivenasalswabs
(#9–#13) from patients diagnosed in 2008 (Table 2). The results
showed low substitution rates for D222G and Q223R (0.01–0.11%
and 0.1–0.41%, respectively), consistent with the results of the
second epidemic, in H1N1pdm.
Discussion
This study used a high-throughput sequencing approach to
analyze more than 2,000 clones from each of eight H1N1pdm
samples obtained in 2009–2010. The results showed that a2,3 sialic
acid-specific viruses containing D222G and/or Q223R substitu-
tions within the HA molecule were present in the upper respiratory
tract as a minor population in patients with mild H1N1pdm
infections in the early phase (May 2009) of the pandemic in Japan.
However, these substitutions nearly disappeared in the samples
fromfivemild casesinDec2010,suggestingthat the D222Gand/or
Table 2. Frequency distribution of N119, D125, E187, G222,
and R223 variants within the HA receptor binding site of
viruses obtained from clinical specimens infected with
influenza A viruses.
Speci-
men
Total
read
K119N
(%)
N125D
(%)
D187E
(%)
D222G
(%)
Q223R
(%)
H1N1pdm #1 3,308 8.59 4.99 0.15 0.74 4.64
1st wave #2 29,607 4.61 1.01 0.72 21.49 2.39
(2009) #3 15,514 3.45 4.88 0 3.16 3.62
H1N1pdm #4 15,485 0.00 1.07 0 0.04 0.57
2nd wave #5 25,429 0.00 1.33 0 0.02 0.53
(2010) #6 14,183 0.02 2.15 0 0.07 0.47
#7 18,046 0.01 1.87 0 0.01 0.63
#8 11,179 3.10 0.66 0 0.05 0.48
H1N1 #9 2,014 0.00 0.00 0 0.1 0.1
Seasonal #10 7,170 0.00 0.00 0 0.04 0.15
(2008) #11 3,652 0.00 0.00 0 0.08 0.16
#12 3,733 0.00 0.00 0 0.11 0.13
#13 7,268 0.00 0.00 0 0.01 0.41
Plasmid (control) 12,428 0.00 0.00 0 0 0.38
doi:10.1371/journal.pone.0030946.t002
Table 3. Frequency of amino acid mutations in the
hemagglutinin receptor binding site in egg-passaged or
MDCK-passaged samples.
Specimen Isolation
Total
Read Mutant Ratio (%)
K119N N125D D187E D222G Q223R
#1 P1 495 0.6 0.2 0 3 95.6
P6 330 0 96.7 12.1 7.9 95.8
MDCK 481 0.2 0.8 1.5 1.9 2.7
#2 P1 340 0.6 12.1 0.3 24.4 70.6
P6 202 60.4 33.7 25.7 60.4 33.2
MDCK 515 0 0 0 0.4 0
#3 P1 300 0.7 0 0 59 0.7
P5 193 49.2 36.3 0 85 0.5
doi:10.1371/journal.pone.0030946.t003
Table 4. Hemagglutination assay using chicken, guinea pig,
and horse erythrocytes with or without a2,3 sialidase
treatment.
Chicken Guinea pig Horse
a2,3 sialidase 2 + 2 + 2 +
#1-P6 512 8 1,024 32 128 16
#2-P6 512 256 512 1,024 64 4.
#3-P5 256 128 512 512 64 4.
#1-MDCK 256 256 512 1,024 128 128
#2-MDCK 32 16 256 256 8 8
doi:10.1371/journal.pone.0030946.t004
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sion. Thus, the newly emergent influenza A viruses may have been
dual specific but not exclusively a2,6-sialic acid-specific during the
early phase of the pandemic and adapted during multiple cycles of
human-to-human transmission. These results are consistent with
previous reports showing that, during previous pandemics, the
receptor binding properties of avian influenza viruses changed after
introduction into mammals [8]. In particular, positions 187 and 222
within the HA of H1 viruses and position 223 in H2 and H3 strains
are critical for receptor binding specificity [8]. In the present study,
the D187E substitution was not striking, suggesting that E187 had
already disappeared in humans, or the original swine lineages, by
May 2009. The N125D mutation, however, was detected (0.66–
2.15%), even in the second wave of the outbreak (Table 2).
However, as far as we know, there is no report indicating that this
mutation affects receptor-binding affinity and specificity. The
K119N mutation was also significantly detected in one specimen
(3.1%) from a patient who had similar clinical symptoms as those
of other patients during the second wave of the outbreak
(Table 2). Neither mutation was detected in specimens of seasonal
H1N1 in 2008, suggesting that further prospective study, as well
as virological study, is required to understand the functions of
these mutations.
HA residue 222 plays a critical role in the binding affinity of the
galactose moiety of sialosaccharides for the RBS. The D222G
mutation would result in a loss of interaction between galactose
and K219 (Figure S4) because of the loss of charge and the side-
chain. In turn, this would open up a cavity on the side of the RBS
to accommodate the a2,3-linked receptor [11,12]. Residue 223
is also important for the binding affinity of galactose and the ter-
minal sialic acid of the receptor. The emergence of a positively
charged and bulky Arginine(R) instead of Glutamine(Q) at this
position would disturb the interaction between K219 and ga-
lactose, leading to decreased virus affinity for the a2,6-linked re-
ceptor (Figure S4) [13,14]. Also, the homology modeling results
showed that the double mutations, D187E and Q223R, would
decrease virus affinity for the a2,6-linked receptor because the salt-
bridge between E187 and R223 would lead to narrowing of the
receptor binding pocket (data not shown).
In this study, we performed deep amplicon sequencing us-
ing Roche/454 GS-Junior technology. We compared the results
obtained by using deep sequencer with those obtained by the con-
ventional Sanger method to evaluate this newly developed te-
chnology. Sequencing analysis using next-generation technology
is necessary to reveal H1N1pdm genetic diversity in detail; our
preliminary sequencing analysis using a conventional cloning ap-
proach failed to detect the D222G mutation in specimen #1
(Figure 1 and Table 2). The frequency of mutations such as D187E
in specimens #1 and #2 and D222G in specimen #2 was not
the same between GS-Junior technology and conventional Sanger
sequencing (Figures 1, S1, S2, and S3, Tables 1 and 2). This
discrepancy might be due to the different number of clones
sequenced in each method. The proportion of HA sequences
observed with D222G and Q223R in the #1 and #2 P6 and in
the #3 P5 PCR products (Table 3) was consistent with results
obtained by direct sequencing analysis using the ABI Sanger
sequencer (Figure S6), suggesting that high-throughput amplicon
sequencing analysis was highly quantitative.
The present study did not confirm whether viruses with the
D222G and/or Q223R substitutions actually replicated in hu-
mans; however, the D222G and Q223R mutant viruses formed
the dominant population when specimens were inoculated into
embryonic chicken eggs (Table 3), indicating that the G222 and
R223 mutants may be able to replicate in humans.
Several reports have shown that the D222G substitution was
associated with severe, and sometimes fatal, cases of H1N1pdm
[10,15,16,17,18]. It has also been reported that two different amino
acids, D and E, may be polymorphic variants at position 222 [19],
and that amino acids, G or N, would be present in potentially more
pathogenic mutants or circulating variants [20]. However, the re-
levance of the mutation at position 222 to H1N1pdm pathogenesis
remains unclear. In this study, D222E, D222N, and D222V
variants were not detected, even when deep sequencing was per-
formed (Table S1). D222G mutants were detected as a minor
population even in mild cases; thus, every patient may have been
exposed to D222G mutant viruses. Minority a2,3 sialic acid-tropic
G222 mutants could be amplified in a2,3 sialic acid expressing cells
in the lower respiratory tract of certain populations, which would
result in severe to fatal respiratory illness in these populations. No
conclusions can be drawn regarding the relationship between the
D222G substitution and pathogenesis from the present study.
Therefore, further study is required to determine whether G222
viruses were ever present as a major population in the lower
respiratory tract of patients with severe or fatal pneumonia due to
H1N1pdm infection.
Materials and Methods
Clinical samples
Three and five individual H1N1pdm-positive nasal swabs were
provided in May 2009 and December 2010, respectively, in
Osaka, Japan. All of the patients examined in 2009 had fever, sore
throat, and cough, but were not hospitalized. They were
administered oseltamivir after nasal swab-sampling. The patients
examined in 2010 had upper respiratory symptoms but were not
hospitalized. As a control, five specimens diagnosed with seasonal
H1N1 in 2008 in Osaka were investigated. The analyzed samples
were unlinked and anonymous in the Osaka Prefectural Institute
of Public Health. This study was approved by the ethical review
committees of the Osaka Prefectural Institute of Public Health and
the Research Institute for Microbial Diseases (RIMD), Osaka
University. The Both ethical committees specifically waived the
need for consent.
RNA extraction
Each nasal swab was collected in Hanks solution and was
centrifuged at 20,000 g for 10 min. The supernatants were
suspended in TRIzol LS reagent (Life Technologies/Invitrogen,
Carlsbad, USA) for 60 min. Total RNA was extracted using
a PureLink
TM RNA Mini Kit (Life Technologies/Invitrogen)
according to the manufacturer’s instructions. Contaminating DNA
was eliminated with DNAase I (Life Technologies/Invitrogen).
One-step reverse transcription-PCR (RT-PCR)
Total RNA was subjected to One-step RT-PCR (SuperScript
III/Platinum Taq HiFi One-step RT-PCR Kit; (Life Technolo-
gies/Invitrogen) to detect the receptor binding site in the HA
molecule. The primers used were as follows: forward primer,
59-416TTGAAAGGTTTGAGATATTC435-39; reverse primer,
59-784CTAGTGTCCAGTAATAGTTC765-39.
Plasmid cloning
Amplified PCR products were cloned into the pGEM-T easy
vector (Promega, Madison, WI). More than one hundred clones
per specimen (109, 103, and 101 clones in #1, #2, and #3,
respectively) were sequenced using conventional Sanger technol-
ogy (Life technologies/Applied Biosystems, Carlsbad, USA).
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and Madin-Darby canine kidney (MDCK) cells
Clinical specimens were injected into 9-day-old embryonated
chicken eggs for virus isolation [21]. After incubation at 37uC for
72 h, the allantoic fluids were collected and filtered (Passage 0: P0).
The samples were then diluted 1–100 fold in phosphate buffered
saline (PBS) and passaged either six (samples derived from #1 and
#2) or five (sample derived from #3) times in embryonated chi-
cken eggs. Identical specimens derived from #1 and #2 were also
inoculated into MDCK cells for virus isolation [22] and the
amplified viruses were serially passaged two or three times in
MDCK cells.
Hemagglutination titration
Viral samples were serially diluted with PBS and added at a
concentration of 0.5% to chicken red blood cells. After incubation
at room temperature for 30 min, hemagglutination was observed.
High-throughput pyrosequencing and data analysis
PCR products were purified using the QIAquickH PCR purifica-
tion kit (Qiagen GmbH, Hilden, Germany) and were ligated with RL
MID adaptors (Roche Diagnostics GmbH, Mannheim, Germany).
The PCR products werefurther purified with Agencourt AMPure XP
beads (Beckman Coulter, Brea, USA). The quality and quantity of
the library was assessed using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, USA) and TBS380 mini fluorometer (A.
Daigger & Company Inc., Vernon Hills, USA), respectively. After
amplifying the samples by emulsion PCR, high-throughput pyro-
sequencing was performed using a GS Junior (Roche Diagnostics
GmbH). Data analysis was performed on each sequence read using
computational tools as described previously [23,24,25].
a2,3 sialidase treatment
100 ml of 10% chicken, guinea pig, or horse red blood cells
were treated with 10 U of a2,3 sialidase (New England Biolabs,
Ipswich, MA) at 37uC for 18 h and were washed with PBS. After
the erythrocyte suspension was diluted to 0.5% (chicken) or 0.75%
(guinea pig and horse), the hemagglutination titer was measured as
described above.
Homology modeling and docking
The crystal structure of HA of influenza virus, A/Brevig
Mission/1/1918 (H1N1) (Protein Data Bank ID code 2WRG),
was used as a template for homology modeling by using a Mo-
lecular Operating Environment. SA a2,6-linked structural analogs
were used as inputs for docking with the model HA structure.
Supporting Information
Figure S1 Alignment of the amino acid sequences within
the receptor binding site of variants other than E187,
G222, and R223. Variants other than E187, G222, and R223
(Figure 1) obtained from clinical specimen #1 from the first wave
of the outbreak.
(TIFF)
Figure S2 Alignment of the amino acid sequences within
the receptor binding site of variants other than E187,
G222, and R223. Variants other than E187, G222, and R223
(Figure 1) obtained from clinical specimen #2 from the first wave
of the outbreak.
(TIFF)
Figure S3 Alignment of the amino acid sequences within
the receptor binding site of variants other than E187,
G222, and R223. Variants other than E187, G222, and R223
(Figure 1) obtained from clinical specimen #3 from the first wave
of the outbreak.
(TIFF)
Figure S4 Stereo views of the homology-based structur-
al model for binding of sialosaccharides to the RBS of
H1N1pdm hemagglutinin. The structural complex of the RBS
of H1N1pdm HA with human receptor (orange) was constructed
using the co-crystal structure of A/Brevig Mission/1/1918 (PDB
ID: 2WRG) as a template. (A) HA of wild type (pink) overlapped
with the HA of D222G mutants (green). Position 222 is shown in
deep colors. Putative interactions salt-bridge between the sugar
and the RBS are shown as black dashed lines. (B) HA of wild type
(pink) overlapped with the HA of Q223R mutants (blue). Q223
and R223 are shown in deep pink and yellow, respectively.
(TIFF)
Figure S5 Kinetics of hemagglutination in viruses
isolated from egg-passaged samples (#1, #2, and #3).
Clinical specimens were injected into 9-day-old embryonated
chicken eggs and incubated for 72 h. Allantoic fluid was collected
(passage 0) and serially passaged in chicken eggs (passage 5–6).
The viral growth of each sample was measured by hemaggluti-
nation assay using (0.5%) chicken red blood cells.
(TIFF)
Figure S6 Direct sequencing analysis of PCR products
(positions 221–227 aa in HA-RBS) amplified from egg-
passaged P6 (#1 and #2) and P5 (#3) viruses using a
conventional ABI sequencer. The arrows indicate nucleotide
substitutions. WT indicates wild type.
(TIFF)
Table S1 Frequency distribution of D222G, D222N, D222V,
and D222E variants within the hemagglutinin receptor binding
site of viruses obtained from clinical specimens (#1–#3).
(TIFF)
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